Intervention

chemotherapy

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 45 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials45
Recruiting2
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

45 shown
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung CancerNCT06121505 · 2024-03-01
RECRUITING
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung NoduleNCT03785574 · 2018-12-24
RECRUITING
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLCNCT07035392 · 2025-06-20
NOT_YET_RECRUITING
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.NCT06306560 · 2024-03-15
NOT_YET_RECRUITING
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLCNCT05351320 · 2022-04-30
UNKNOWN
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung CancerNCT05186506 · 2022-01-01
NOT_YET_RECRUITING
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in RussiaNCT04943497 · 2021-07-27
COMPLETED
A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR MutationNCT04951648 · 2021-07-15
UNKNOWN
A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary MetastasisNCT04888806 · 2021-06-01
UNKNOWN
Adjuvant Chemotherapy With or Without Intercalated IcotinibNCT03983811 · 2019-07-01
UNKNOWN
Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung CancerNCT03589950 · 2018-08-01
UNKNOWN
A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung CancerNCT03547804 · 2018-05-31
COMPLETED
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung AdenocarcinomaNCT02621333 · 2015-10-01
TERMINATED
The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With ChemotherapyNCT02771756 · 2015-05-01
UNKNOWN
Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line ChemotherapyNCT01648517 · 2012-07-27
COMPLETED
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerNCT01368263 · 2011-09-01
TERMINATED
Standard Chemotherapy With of Without Axitinib in Malignant MesotheliomaNCT01211275 · 2009-05-22
COMPLETED
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung CancerNCT00768755 · 2009-01-01
COMPLETED
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneNCT00993694 · 2009-01-01
COMPLETED
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryNCT00732563 · 2008-07-16
COMPLETED
Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon CancerNCT00873600 · 2007-10-01
WITHDRAWN
Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast CancerNCT00639366 · 2007-02-01
COMPLETED
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With ChemoNCT00382018 · 2006-10-01
COMPLETED
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast CancerNCT00398437 · 2006-09-01
UNKNOWN
Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerNCT00403182 · 2006-05-01
WITHDRAWN
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By SurgeryNCT00373191 · 2006-05-01
COMPLETED
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)NCT00452803 · 2006-04-01
UNKNOWN
Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast CancerNCT00870168 · 2006-01-01
COMPLETED
First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never SmokerNCT00455936 · 2005-10-01
COMPLETED
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By SurgeryNCT00253409 · 2005-05-01
UNKNOWN
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the PleuraNCT00601848 · 2004-11-01
TERMINATED
Premenopausal Endocrine Responsive Chemotherapy TrialNCT00066807 · 2003-08-01
TERMINATED
Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I StudyNCT00256815 · 2003-03-01
COMPLETED
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast CancerNCT00074152 · 2002-07-01
COMPLETED
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer SurgeryNCT00033397 · 2002-02-01
COMPLETED
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNCT00005848 · 2000-04-01
COMPLETED
Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerNCT00039039 · 2000-02-01
UNKNOWN
Gene Therapy Plus Chemotherapy in Treating Patients With Breast CancerNCT00004038 · 1999-01-01
COMPLETED
CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous TherapyNCT00004026 · 1998-12-01
TERMINATED
Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung CancerNCT00004202 · 1998-10-01
COMPLETED
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryNCT00003387 · 1998-07-01
COMPLETED
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II MesotheliomaNCT00003974 · 1997-08-01
COMPLETED
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung CancerNCT00002519 · 1997-01-01
COMPLETED
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid TumorsNCT00002677 · 1995-08-01
COMPLETED
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerNCT00003536
WITHDRAWN

Common conditions

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

Trial status mix

COMPLETED22
UNKNOWN10
TERMINATED5
NOT_YET_RECRUITING3
WITHDRAWN3
RECRUITING2

Phase mix

PHASE220
PHASE39
NA7
PHASE17
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.